RP

Royalty Pharma PLCNASDAQ RPRX Stock Report

Last reporting period 30 Sep, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

12.418

Large

Exchange

XNAS - Nasdaq

View Section: Company Analysis

Royalty Pharma Rating

RP

RPRX stock rating score is 84/100. Royalty Pharma is aSomewhat Risky Investment.

The in-depth assessment covers such aspects as the profitability and solvency of the company, management efficiency, and growth sustainability. Our rating serves as an answer to whether the company`s shares are generally reasonable for purchase. The higher company rating score is, the more stock is attractive for investment.

Eyestock Rating

Last update 08.11.2024

84/100

Moderate score

Rating Breakdown

  • Profitability score

    44

    /25

  • Solvency score

    19

    /25

  • Efficiency score

    18

    /25

  • Stability score

    3

    /25

Royalty Pharma PLC Rewards and Warnings

The assessment of the quality of a business is based on quantitative analysis of 10 key financials taken from the company's statements. Pay close attention to the cons, if any, before making a decision.

Financial

Check

Value

Net Profit Margin

51 %

Earnings quality

244 %

Gross Margin

Royalty Pharma PLC's Historical Rating

How has the company's valuation changed in the past?

A quick analysis will help you understand how stable financial indicators are overall.


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Discover High-rated Companies


View Section: Valuation